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To determine whether transplacental transmission 
could explain overwintering of bluetongue virus in the United 
Kingdom, we studied calves born to dams naturally infected 
during pregnancy in 2007–08. Approximately 33% were in-
fected transplacentally; some had compromised health. In 
all infected calves, viral load decreased after birth; no evi-
dence of persistent infection was found.
B
luetongue virus (BTV) is generally transmitted be-
tween ruminant hosts by Culicoides biting midges, 
and infection may result in the disease called bluetongue. 
In 2006, a strain of BTV-8 caused the ﬁ  rst outbreak of 
bluetongue in northern Europe (1). Although adult Culi-
coides midges are absent from this region during winter 
for long enough to interrupt normal transmission, BTV-8 
survived the winters of 2006–07 and 2007–08.
Several mechanisms have been suggested to explain 
the overwintering of BTV, one of which is transplacen-
tal transmission (2). Tissue-attenuated strains of BTV are 
sometimes capable of crossing the placenta and infecting 
fetuses in utero (3), and transplacental infection has been 
reported from the ﬁ  eld after use of live attenuated vaccines 
(4). However, many wild-type strains of BTV failed to 
cross the placental barrier when cows were infected dur-
ing pregnancy (5). Additionally, although a few studies 
have reported experimental transplacental infection with 
wild-type strains, these studies did not recover infectious 
virus from live offspring (although many ﬁ  eld strains do 
not grow in tissue culture) and suggested that fetal infec-
tion often resulted in deformation, stillbirth, or abortion 
(6,7). Collectively, this information led to the assumption 
that only viruses passaged in tissue culture had the potential 
to overwinter by transplacental transmission (8). However, 
in 2008, nonlethal transplacental transmission of BTV-8 
was detected in Northern Ireland (9). To examine the oc-
currence, rate, and consequences of transplacental BTV-8 
transmission in the United Kingdom, we studied calves 
born to dams naturally infected with BTV-8 during preg-
nancy.
The Study
After obtaining owners’ permission, we sampled 
calves born to previously infected dams during the vec-
tor-free period of December 20, 2007 to March 15, 2008. 
Farmers were also asked to report any births, abortions, or 
stillbirths from BTV-infected dams outside the vector-free 
period. Blood samples from live calves were taken as soon 
as possible after birth (usually within 4 days) and tested by 
using a real-time reverse transcription–PCR (rRT-PCR) 
(10) and the Pourquier c-ELISA kit (IDEXX, Chalfont St. 
Peter, UK). When possible, information about the health 
of the calf was obtained, dams were sampled alongside 
their calves, and placenta samples were collected. Calves 
with positive BTV RNA results were resampled at 2–3 
week intervals. In total, 61 calves were tested and 21 (in-
cluding 1 set of twins) had detectable levels of BTV RNA 
in their blood or organs (online Appendix Table, avail-
able from www.cdc.gov/EID/content/15/12/2025-appT.
htm). The transplacental transmission rate was 33% (95% 
conﬁ  dence interval 22%–47%).
All calves except calf 21 and calf X, each of which had 
not consumed colostrum before sampling, had antibodies 
against BTV. Calf 21 was also negative for BTV RNA, but 
calf X showed the highest viral load in the blood (online 
Appendix Table). Virus isolation in KC cells (11) was at-
tempted for all calf blood samples with a cycle threshold 
(Ct) <29, but virus was isolated from calf X only. Viral 
RNA load in all calves tested declined over time, and al-
most all calves were rRT-PCR negative by the end of the 
study (Table).
When the calves were ﬁ  rst sampled, 52 dams were also 
tested. The RNA load in the calves always exceeded that 
of their dams, and 7 of the 20 dams giving birth to BTV-
positive calves had no detectable viremia.
Of the 21 BTV RNA–positive calves, 5 had compro-
mised health. Calves Y, X, and 33 were born weak and died 
within hours, days, and weeks after birth, respectively, and 
calves 13 and 29 exhibited dummy calf syndrome (12). All 
calves except calf 33 were examined postmortem and had 
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comm.). Although calf X died of colisepticemia, this illness 
probably resulted from the calf’s weakness and inability to 
consume colostrum. No infectious cause for the early post-
natal death of calf Y, other than bluetongue, was identiﬁ  ed; 
pathologic ﬁ  ndings for calves 13 and 29 are described else-
where (S.W. et al., unpub. data). Calf 27, which had nega-
tive BTV test results, was born with hypermobility of the 
fetlock joints, unilateral carpal valgus, and arthrogryposis. 
All other calves were reported to be healthy.
Time windows for possible in utero infection of each 
calf were calculated according to the BTV testing history of 
the dam and the birth date of the calf (Figure). These win-
dows were used to investigate effect of stage of gestation on 
the probability of transplacental transmission. To account 
for uncertainty in the date of infection, we used Bayes-
ian methods (online Technical Appendix, available from 
www.cdc.gov/EID/content/15/12/2025-Techapp.pdf). The 
probability of transplacental transmission increased with 
the time of gestation during which the dam became infected 
(β1 0.033; 95% credibility interval 0.014–0.063).
Conclusions
This detailed ﬁ  eld study, which combines data on BTV 
infection in cows with data on transplacentally acquired 
infection in their offspring, demonstrates that the BTV-8 
strain circulating in northern Europe can cross the bovine 
placenta in a high proportion (33%) of cases and infect 
calves when dams are infected during pregnancy. A simi-
lar study in continental Europe suggested a rate of ≈10% 
(13). However, because the transmission season was longer 
in some of these countries, many seropositive dams could 
have been infected before pregnancy, leading to underesti-
mation of the probability of transplacental infection. In our 
study, we tested only calves from dams infected between 
August and December 2007 and known to be pregnant at 
the time of infection. Furthermore, analysis of our data sug-
gests that transplacental transmission is more likely when 
infection occurs later in gestation; indeed, most of the dams 
in this study would have been in the second or third ges-
tation trimester when infected (Figure), which may have 
increased our estimated rate over that found in continental 
Europe.
Transplacental transmission is of particular concern 
for policy makers because it may result in the birth of 
immune-tolerant, persistent carriers, as has happened with 
bovine viral diarrhea virus (14). In our study, all BTV-pos-
itive calves other than X and Y were tested after they had 
received colostrum and, hence, maternal antibodies. The 
presence of BTV antibodies in calf Y suggests that fetal an-
tibody formed in response to in utero infection, yet calf X 
had no detectable antibodies against BTV despite strongly 
positive rRT-PCR results. Calf X was infected late in gesta-
tion (Figure), when it should have been capable of mount-
ing its own antibody response (15). Antibody-negative 
PCR-positive calves have been reported elsewhere (13). 
Follow-up testing is needed to assess whether such calves 
remain persistently infected; however, because calf X died 
a few days after birth, follow-up testing was not possible. 
RNA declined in all retested calves (Table); most were 
PCR-negative by the end of the study, including dummy 
calf 13. Therefore, our results do not suggest that transpla-
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Table. Bluetongue virus real-time reverse transcription–PCR results from follow-up sampling of calves with initial positive results,
United Kingdom, December 20, 2007, to March 15, 2008* 
Retest results, age, d (Ct) 
Calf no. 
First BTV result, 
age, d (Ct)  Retest 1  Retest 2  Retest 3  Retest 4  Retest 5 
Age, d,  when 
PCR negative 
Estimated
gestation, d†
1 15 (25)  28 (26)  44 (26)  58 (28.5)  72 (32.5)  91 (neg)  91 82–219
3 38 (31)  47 (32)  61 (35.5)  81 (neg)  NT NT 81 106–243
10 79 (32)  106 (33.5)  120 (34)  137 (neg) 158 (neg)  NT 137 140–197
12 81 (28)  108 (30)  122 (31)  139 (34)  160 (neg)  NT 160 142–199
13 4 (33)  31 (36.5)  45 (neg)  62 (neg)  83 (neg)  NT 45 65–122
14 28 (26)  48 (29)  55 (32)  69 (neg)  86 (neg)  107 (neg)  69 154–209
15 70 (32)  97 (neg)  111 (neg)  128 neg)  149 (neg)  NT 97 196–251
20 17 (31)  44 (32.5)  58 (33.5)  75 (neg)  96 (neg  NT 75 78–128
25 27 (29.5)  41 (29)  55 (30.5)  69 (36)  NT NT >69‡ 145–202
28 1 (23)  26 (25)  35 (26)  NT NT >35‡ 101–181
29 1 (27)  12 (27.5)  Calf died  45–182
41 47 (28)  61 (29.5)  NT NT NT NT >61‡ 79–126
45 22 (27)  40 (30.5)  61 (34)  NT NT NT >61‡ 52–130
47 25 (26.5)  39 (29)  66 (38)  NT NT NT >66‡ 52–189
49 (twin with 50)  46 (29)  60 (36)  87 (neg)  NT NT NT 87 73–136
50 (twin with 49)  46 (29)  60 (36.5)  87 (neg)  NT NT NT 87 73–136
55 21 (25.5)  48 (31.5)  NT NT NT >48‡ 34–172
*BTV, bluetongue virus; Ct, cycle threshold; neg, negative: NT, not tested. 
†Estimated stage of gestation at which transplacental infection may have occurred 
‡These calves could not be followed up for farm management reasons or because the project had ended. Transplacental Transmission of BTV-8, Cattle
cental infection with BTV-8 results in subclinical, persis-
tent carriers. Nonetheless, the ﬁ  nding that some calves may 
be born with deformaties after the virus has cleared may 
lead to underestimation of the economic effects of BTV; 
calf 27, which was born with limb deformities to a BTV 
positive dam, could be such a case.
Live virus has been successfully isolated from only 4 
transpacentally infected calves (including calf X described 
in this study), all of which received either no maternal co-
lostrum or only pooled colostrum (9,13). Further work is 
needed to assess whether infectious virus can be isolated 
from healthy transplacentally infected calves that have 
colostrum-derived maternal antibodies, because infectious 
virus needs to be present if transplacental infection is to 
play a major role in overwintering. In conclusion, future 
emerging BTV strains should be considered to have the po-
tential for transplacental transmission until investigations 
show otherwise.
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used to calculate the window of gestation when 
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Technical Appendix, available from www.cdc.gov/
EID/content/15/12/2025-Techapp.pdf, for details). 
The calculated infection windows are shown in red 
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did occur) and in blue for BTV-negative calves 
(transplacental infection did not occur). Because 
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